Back to search

Article

Development and External Validation of a Transcriptomic Prognostic Signature in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

2026-03-08

Abstract excerpt

<title>Abstract</title> <p>Purpose Triple-negative breast cancer (TNBC) subtype is the most aggressive representative of breast cancer; it does not have any reliable prognostic biomarkers for clinical stratification of the risk associated with the disease. This study is designed for the development and external validation of a transcriptome-based prognostic gene signature which can be utilised for stratifying TN...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
58f6eba8-a7a1-5a80-94a0-cabd8fa15120
DOI
10.21203/rs.3.rs-8702492/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and External Validation of a Transcriptomic Prognostic Signature in Triple-Negative Breast Cancer Treated with Neoadjuvant ChemotherapyDOI 10.21203/rs.3.rs-8702492/v1
Development of a Prognostic Model Based on Identification of EMT-related LncRNAs in Triple Negative Breast CancerSemantic proximity
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerSemantic proximity
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancerSemantic proximity
The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity
The analysis of transcriptomic signature of TNBC – searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivitySemantic proximity
An 8-lncRNA signature predicts survival of triple-negative breast cancer patients without germline BRCA1/2 mutationSemantic proximity
An 8-lncRNA Signature Predicts Survival of Triple-Negative Breast Cancer Patients Without Germline BRCA1/2 MutationSemantic proximity
Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity
Research on Constructing a prognosis prediction Model of Breast Cancer LncRNA Based on the TCGA DatabaseSemantic proximity
Transcriptome Analysis Derives a Novel Prognostic 7-mRNA Signature in Early-Stage Triple-Negative Breast CancerSemantic proximity
Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional ValidationSemantic proximity
Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast CancerSemantic proximity
Select a neighboring publication to make it the new centre.